FDA record shows earlier accelerated nod for mirvetuximab soravtansine-gynx, date unclearNov 9Regulatory decisionAbbViemirvetuximab soravtansineUpdated
AbbVie posts KEEPsAKE 2 update; registers pediatric vitiligo and real-world MIRV studiesOct 29Weekly roundup, 7 itemsABBV-706ABBV-722Updated
AbbVie registers two real-world studies for atogepant and mirvetuximab soravtansine-gynxJul 8Weekly roundup, 2 itemsAbbVieatogepant